Skin Analytics

Skin Analytics is at the forefront of transforming skin cancer detection through innovative AI solutions. Dedicated to creating a world where no one dies from skin cancer, Skin Analytics deploys its cutting-edge AI medical device, DERM, to establish the most advanced skin cancer pathways globally. Skin Analytics partners proudly with NHS dermatology teams, implementing AI-powered pathways that enable the early discharge of benign lesions, thereby tackling backlogs, reducing out-patient delays, and prioritizing patients needing life-saving treatment.

Working with the NHS since 2020, Skin Analytics' DERM is deployed across numerous primary and secondary care organizations. DERM is the first and only AI skin cancer pathway within the NHS, recommended by the National Institute for Health and Care Excellence (NICE) and holding a Class III CE mark as a Medical Device for skin cancer. Having supported pathways that have seen over 170,000 NHS patients and identified more than 15,500 cancers, Skin Analytics has helped NHS organizations avoid up to 95% of face-to-face appointments in secondary care. The primary address of Skin Analytics is Smithfield Business Centre, Second Floor, 5 Sr John's Ln London, EC1M 4BH, GB.

Skin Analytics also provides remote skin assessment services for Bupa and Vitality, ensuring better patient outcomes that are sustainable for health systems worldwide. With a commitment to innovation and patient care, Skin Analytics continues to lead the way in AI-driven healthcare solutions. We invite the manager of Skin Analytics to create a customized and exclusive company showcase and product listing on our platform.